Developing cardiac inflammatory organoid models incorporating multiple cell lineages is vital for novel therapies.

Merck's strong drug pipeline, oncology leadership, and 3.8% dividend yield make it a top long-term investment pick. Learn ...

As luck would have it, many of the expert-backed products we’ve featured over the years are on sale for October Prime Day.

New findings show Telomir-1 shuts down cellular energy pathways and mitochondrial function in aggressive breast cancer cells, ...

Shattuck Labs, Inc. ( NASDAQ: STTK) The United European Gastroenterology (UEG) Congress UEG Week 2025 October 8, 2025 10:00 AM EDT ...